Name | (E)-methyl 2-(2-methoxy-5-((2',4',6'-trimethoxystyrylsulfonyl)methyl)phenylamino)acetate |
---|---|
Synonyms |
methyl-{N-[2-methoxy-5-methylene(2',4',6'-trimethoxystyrylsulfonyl)-phenyl]amino}acetate
methyl (E)-2-(5-((2,4,6-trimethoxystyrylsulfonyl)methyl)-2-methoxyphenylamino)acetate methyl 2-(5-((2,4,6-trimethoxystyrylsulfonyl)methyl)-2-methoxyphenylamino)acetate (E)-2,4,6-trimethoxystyryl-3-(carbomethoxymethylamino)-4-methoxybenzyl-sulfone (E)-2,4,6-trimethoxystyryl 3-(carbomethoxymethylamno)-4-methoxybenzyl-sulfone |
Description | Anticancer agent 9, a glycine derivative, is an anticancer agent. Anticancer agent 9 can inhibit tumor cells viability of myelogenous leukemia and human prostate cancer[1]. |
---|---|
Related Catalog | |
In Vitro | Anticancer agent 9 (compound 24) (96 h) inhibits the cell growth, with IC50s of 0.1 μM and 0.1 μM for K562 and DU145 cells, respectively[1]. |
References |
Molecular Formula | C22H27NO8S |
---|---|
Molecular Weight | 465.51700 |
Exact Mass | 465.14600 |
PSA | 117.77000 |
LogP | 4.04540 |